QKBGX
Price
$23.64
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
330.95M
RLBFX
Price
$41.20
Change
+$0.11 (+0.27%)
Updated
Jun 2 closing price
Net Assets
278.87B
Interact to see
Advertisement

QKBGX vs RLBFX

Header iconQKBGX vs RLBFX Comparison
Open Charts QKBGX vs RLBFXBanner chart's image
QKBGX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
QKBGX vs. RLBFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKBGX is a Hold and RLBFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 279B vs. QKBGX (331M). RLBFX pays higher dividends than QKBGX: RLBFX (2.02) vs QKBGX (1.35). QKBGX was incepted earlier than RLBFX: QKBGX (19 years) vs RLBFX (24 years). QKBGX (1.05) is less costly to investors than RLBFX (0.30). QKBGX is a more actively managed with annual turnover of: 82.00 vs. RLBFX (50.00). QKBGX has a lower initial minimum investment than RLBFX: QKBGX (0) vs RLBFX (250). RLBFX annual gain was more profitable for investors over the last year : 18.07 vs. QKBGX (8.75). RLBFX return over 5 years is better than : 37.10 vs. QKBGX (12.24).
QKBGXRLBFXQKBGX / RLBFX
Total Expense Ratio1.050.30350%
Annual Report Gross Expense Ratio1.050.30350%
Fund Existence19 years24 years-
Gain YTD6.3919.81765%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets331M279B0%
Annual Yield % from dividends1.352.0267%
Returns for 1 year8.7518.0748%
Returns for 3 years32.4146.8169%
Returns for 5 years12.2437.1033%
Returns for 10 years64.3489.7372%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VGZ2.390.02
+0.84%
Vista Gold Corp
SM32.940.27
+0.83%
SM Energy Company
CUBWU10.85N/A
N/A
Lionheart Holdings
PLSE24.26-0.41
-1.66%
Pulse Biosciences
ATOS4.85-0.26
-5.09%
Atossa Therapeutics Inc.